Related Experiment Videos
[Contraception with the intrauterine pessary Progestasert]
Fortschritte Der Medizin
|September 7, 1978
Summary
The Progestasert intrauterine device (IUD) showed a low pregnancy rate and reduced dysmenorrhea. However, increased spotting and menstrual duration were observed in this clinical trial.
Area of Science:
- Reproductive Medicine
- Contraception
- Gynecology
Context:
- A prospective study evaluated the Progestasert intrauterine device (IUD) in 131 women over a 3-year period.
- The study focused on the safety, efficacy, and menstrual side effects of this novel IUD.
Purpose:
- To assess the performance of the Progestasert IUD, including pregnancy rates, expulsion, and medical removals.
- To analyze changes in menstrual cycle characteristics such as duration, intensity, interval, spotting, and dysmenorrhea.
Summary:
- The Progestasert IUD demonstrated a low incidence of pregnancy (one intrauterine, one extrauterine) and one expulsion over 1496 application months.
- While menstrual bleeding intensity decreased, duration and interval slightly increased. Spotting was more frequent, particularly in the first month, but dysmenorrhea significantly reduced after two months.
- Laboratory tests (ESR, WBC, hemoglobin, hematocrit, cytology) showed no pathological changes.
Impact:
- The Progestasert IUD offers a contraceptive option with reduced dysmenorrhea, though potential users should be aware of increased spotting and altered menstrual patterns.
- Findings contribute to understanding the long-term effects and patient experience with early hormonal IUDs.
- This research provides valuable data for clinicians counseling patients on IUD selection and management.